T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome

被引:0
|
作者
Zoellner, Anna-Katharina [1 ]
Fritsch, Susanne [1 ]
Prevalsek, Dusan [1 ]
Koehnke, Thomas [1 ]
Hubmann, Max [1 ]
Lippl, Stephanie [1 ]
Kruger, Stephan [1 ]
Hellmuth, Johannes [1 ]
Mumm, Friederike [1 ]
Ledderose, Georg [1 ]
Barlow, Sophie [1 ]
Subklewe, Marion [1 ]
Spiekermann, Karsten [1 ]
Hiddemann, Wolfgang [1 ]
Albert, Michael H. [2 ]
Schmid, Christoph [3 ]
Hausmann, Andreas [4 ]
Tischer, Johanna [1 ]
机构
[1] Univ Munich, Hosp Munich Grosshadern, Dept Internal Med 3, Hematopoiet Stem Cell Transplantat, Munich, Germany
[2] Dr von Hauner Univ Childrens Hosp, Pediat Hematol Oncol, Munich, Germany
[3] Univ Munich, Klinikum Augsburg, Dept Hematol & Oncol, Munich, Germany
[4] Klinikum Munchen Schwabing, Dept Internal Med 1, Munich, Germany
关键词
D O I
10.1016/j.bbmt.2015.11.870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
547
引用
收藏
页码:S364 / S364
页数:1
相关论文
共 50 条
  • [1] T-cell-replete HLA-haploidentical transplantation using post-transplantation high-dose cyclophosphamide post-transplantation in high-risk and advanced ALL: Feasibilty and early outcome
    Zoellner, A. -K.
    Fritsch, S.
    Prevalsek, D.
    Koehnke, T.
    Hubmann, M.
    Lippl, S.
    Kruger, S.
    Hellmuth, J.
    Mumm, F.
    Barlow, S.
    Ledderose, G.
    Subklewe, M.
    Spiekermann, K.
    Hiddemann, W.
    Albert, M.
    Schmid, C.
    Hausmann, A.
    Tischer, J.
    [J]. Oncology Research and Treatment, 2015, 38 : 35 - 35
  • [2] Alternative Donor Transplantation Using Intensified Conditioning, T-Cell-Replete HLA-Haploidentical Grafts and Post-Transplantation Cyclophosphamide in the Treatment of High-Risk and Advanced ALL: Feasibility and Outcome
    Zoellner, Anna-Katharina
    Prevalsek, Dusan
    Kohnke, Thomas
    Fritsch, Susanne
    Schulz, Christoph
    Hubmann, Max
    Lippl, Stephanie
    Kruger, Stephan
    Habe, Sarah
    Berking, Sophie
    Fraccaroli, Alessia
    Ledderose, Georg
    Stemmler, Hans-Joachim
    Spiekermann, Karsten
    Hiddemann, Wolfgang
    Bug, Gesine
    Hausmann, Andreas
    Schmid, Christoph
    Albert, Michael H.
    Tischer, Johanna
    [J]. BLOOD, 2016, 128 (22)
  • [3] HLA-haploidentical transplantation using T-cell-replete grafts and high-dose cyclophosphamide post-transplantation in the treatment of multiple myeloma: a single center experience
    Haebe, S.
    Totok, G.
    Prevalsek, D.
    Fritsch, S.
    Hubmann, M.
    Zoellner, A. -K.
    Koehnke, T.
    Schulz, C.
    Ledderose, G.
    Hausmann, A.
    Hiddemann, W.
    Tischer, J.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S356 - S357
  • [4] HLA-haploidentical transplantation using T-cell-replete grafts and high-dose cyclophosphamide post-transplantation in the treatment of relapsed/refractory T-cell lymphoma/leukemia
    Haebe, S.
    Fraccaroli, A.
    Prevalsek, D.
    Zoellner, A-K
    Fritsch, S.
    Schulz, C.
    Ledderose, G.
    Hausmann, A.
    Dreyling, M.
    Hiddemann, W.
    Tischer, J.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S492 - S492
  • [5] Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced -Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High Risk AML and MDS
    Prevalsek, Dusan
    Fritsch, Susanne
    Hubmann, Max
    Engel, Nicole
    Zoellner, Anna-Katharina
    Koehnke, Thomas
    Buecklein, Veit Leonhard
    Schulz, Christoph
    Mumm, Friederike
    Rieger, Christina Theresa
    Ledderose, Georg
    Stemmler, Hans-Joachim
    Spiekermann, Karsten
    Hiddemann, Wolfgang
    Hausmann, Andreas
    Tischer, Johanna
    [J]. BLOOD, 2015, 126 (23)
  • [6] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    Fuchs, E. J.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S31 - S36
  • [7] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    E J Fuchs
    [J]. Bone Marrow Transplantation, 2015, 50 : S31 - S36
  • [8] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
  • [9] Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
    Munchel, Ashley
    Kesserwan, Chimen
    Symons, Heather J.
    Luznik, Leo
    Kasamon, Yvette L.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. PEDIATRIC REPORTS, 2011, 3 : 43 - 47
  • [10] Sequential therapy in the setting of HLA-haploidentical transplantation utilizing T-cell-replete grafts and post-transplantation high-dose cyclophosphamide in the treatment of relapsed and refractory acute myeloid leukemia and myelodysplastic syndrome
    Prevalsek, D.
    Fritsch, S.
    Hubmann, M.
    Zoellner, A. -K.
    Koehnke, T.
    Buecklein, V. L.
    Mumm, F.
    Haebe, S.
    Witkowski, L.
    Ledderose, G.
    Stemmler, H. -J.
    Spiekermann, K.
    Hiddemann, W.
    Hausmann, A.
    Tischer, J.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S29 - S30